Dr. Mark Yazer is a professor of pathology at the university of Pittsburgh. He is also an adjunct professor of clinical immunology at the university of southern Denmark, and a visiting professor of pathology at Tel Aviv University. His research interests include blood use in massive bleeding, RhD alloimmunization, and whole blood. He has published over 300 peer reviewed papers and is an associate editor of the journal Hematology. He is on the editorial board of 4 other journals. He has lectured on his research and on the practice of transfusion medicine in more than 25 countries. He is on the board of directors of the THOR (Trauma, Hemostasis, and Oxygenation Research) Network and is the co-chairman of the AABB/THOR working group, and is a United Nations subject matter expert for hemotherapy and emergency medicine. He is also a co-editor of the THOR research supplement in Transfusion. He has received grant funding from the American National Institutes of Health, the American department of defense, and the American military-based DARPA group.